Tender germany-berlin: pharmaceutical products-1504515

This tender with title Germany-Berlin: Pharmaceutical products has been published on Bidding Source portal dated 27 Jan 2019 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Tender Title :

Germany-Berlin: Pharmaceutical products

Tender Type :

Contract notice

Reference No. :

2019/S 017-035321

Country :

Germany

Province/City :

Germany-Berlin

Publish Date :

27 Jan 2019

Closing Date :

28 Feb 2021

Notice Language :

English

Tender Categories (CPVs) :

Pharmaceutical products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Germany - Conclusion of non-exclusive discount agreements according to § 130a Para. 8 SGB V for the in II.2.4. mentioned active ingredients with the possibility of conclusion within the framework of the so-called open-house procedure. -- Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4. genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens. Germany Germany - Conclusion of non-exclusive discount agreements according to § 130a paragraph 8 SGB V for the active ingredient tafamidis / tafamidis meglumin -- Abschluss von nicht-exklusiven Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Tafamidis / Tafamidis meglumin Germany Germany - Conclusion of non-exclusive discount agreements according to § 130a paragraph 8 SGB V for the active ingredient iron(III) sodium D-gluconate complex -- Abschluss von nicht-exklusiven Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Eisen(III)-Natrium-D-gluconat-Komplex Germany Germany - Conclusion of non-exclusive drug discount agreements according to § 130a Para. 8 SGB V by means of a so-called open house model for the active ingredient epoetin zeta (recombinant human erythropoietin) -- Abschluss nicht-exklusiver Arzneimittel-Rabattvereinbarungen nach § 130a Abs. 8 SGB V im Wege eines sog. Open-House-Modells zum Wirkstoff Epoetin zeta (rekombinantes humanes Erythropoetin) Germany Germany - Conclusion of non-exclusive drug discount agreements according to § 130a Para. 8 SGB V by means of a so-called open house model for the active substance fondaparinux (ATC code according to WHO: B01AX05) -- Abschluss nicht-exklusiver Arzneimittel-Rabattvereinbarungen nach § 130a Abs. 8 SGB V im Wege eines sog. Open-House-Modells zum Wirkstoff Fondaparinux (ATC-Code nach WHO: B01AX05) Germany Germany - Special care Wolfsburg -- Spezialversorgung Wolfsburg Germany Open House Biologika Rabattverträge 2023-05 - Dornase alfa -- Pharmaceutical products Germany Arzneimittelrabattverträge mit Beitrittsoption - 0018-RVBEITR.61-2023 -- Pharmaceutical products Germany Arzneimittelrabattverträge mit Beitrittsoption - 0015-RVBEITR.60-2023 -- Pharmaceutical products Germany Degree non-excl. drug discount agreements according to § 130a para. 8 sgb v iwe so-called open-house model for ws metoprolol/hct (official atc code: c07bb22) - Germany Germany

Germany-Berlin: Pharmaceutical products

General Information

Germany

Similar Tenders

Pharmaceutical products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com